Philip Storey, MD
Ophthalmology · Austin, TXNPI 1053614453
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 37.5% of the total. Among ophthalmology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 200 payments — averaging $806.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$60K
- Genentech USA, Inc.$53K
- Baxter Healthcare$24K
- Apellis Pharmaceuticals, Inc.$7K
- Genentech, Inc.$4K
- Ocular Therapeutix, Inc.$4K
- plus $8K from 16 others
Across 503 payments — averaging $3899.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$1.1M
- Eyepoint US, Inc.$812K
- AbbVie$13K
- F. Hoffmann-la Roche AG$3K
What the payments were for
- Consulting fees$58,53036%
- Speaking & faculty fees$82,15651%
- Travel & lodging$12,5728%
- Food & beverage$7,8745%
- Gifts$1760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 53 | $60,435 |
| Genentech USA, Inc. | 50 | $53,380 |
| Baxter Healthcare | 24 | $24,230 |
| Apellis Pharmaceuticals, Inc. | 18 | $6,773 |
| Genentech, Inc. | 5 | $4,437 |
| Ocular Therapeutix, Inc. | 3 | $3,880 |
| F. Hoffmann-la Roche AG | 4 | $3,574 |
| AbbVie | 9 | $2,372 |
| Regeneron | 7 | $637 |
| Harrow Eye, LLC | 1 | $365 |
| Alimera Sciences, Inc. | 6 | $235 |
| Biotissue Holdings Inc. | 1 | $176 |
| Carl Zeiss Meditec, Inc. | 1 | $176 |
| Novartis | 2 | $165 |
| Astellas Pharma US Inc | 6 | $158 |
| Alcon | 2 | $142 |
| ANI Pharmaceuticals, Inc. | 2 | $59 |
| Bausch & Lomb Americas Inc. | 2 | $44 |
| Halozyme Inc | 1 | $21 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Biogen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA HD$50,139
- VABYSMO$49,191
- Hillrom - RetinaVue 700 Imager$24,230
- Hillrom - RetinaVue Network$24,230
- EYLEA$10,044
- Syfovre$6,165
- Lucentis$3,911
- OZURDEX$2,213
- SUSVIMO$1,021
- IHEEZO$365
- CLARUS$176
- Constellation$118
- Iluvien$117
How this compares
$161,308 in reported general payments places this provider in the 95th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 81 | $3,243 |
| Ketorolac Tromethamine | 70 | $2,232 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 130 | $1,399 |
| Atropine Sulfate | 20 | $636 |
| Timolol Maleate | 44 | $397 |
| Brimonidine Tartrate | 25 | $394 |
| Dorzolamide Hcl | 25 | $310 |
| Latanoprost | 17 | $160 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Austin
- Chirag JhaveriAustin$240K
- Sheila BarbarinoAustin$232K
- Aaron RollerAustin$202K
- Robert WongAustin$113K
- Farhan IrshadAustin$111K
- Edward WoodAustin$110K
- Ryan YoungAustin$105K
- Steven DellAustin$94K
- Shelley GhafooriAustin$73K
- Michael SingerSan Antonio$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.